• FAQ
  • Glossary
Fermer

FAQ

Why are animal models used when testing the safety of a new therapy?
What role do preclinical and clinical trials play in ensuring patient safety?
Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

Voir toutes les FAQ

Fermer

Glossary

Accelerated assessment
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Advanced Therapy Investigational Medicinal Product (ATIMP)
Advanced Therapy Medicinal Product (ATMP)
Advertising 
Antibody
Antigen
Base editors

Voir le glossaire complet

Jonathan's story: Stem Cells and Myelin

Related topics:
Multiple Sclerosis Neurological Disorders Clinical Trials Research

Part of the Wellcome - MRC Cambridge Stem Cell Institute Patient Stories series.

Jonathan met with Professor David Rowitch at the Wellcome - MRC Cambridge Stem Cell Institute to learn about some of the latest research into myelin repair.

Remerciements et droits d'auteur

With thanks to Jonathan Green, David Rowitch, Ana Amaral and HEFCE.

Copyright: Wellcome - MRC Cambridge Stem Cell Institute / University of Cambridge.

Retour en haut de page
Le contenu de cette page vous a-t-il été utile ? Envoyez-nous vos commentaires